2024-03-28 10:38:32 ET
Summary
- The SPDR S&P Pharmaceuticals ETF offers broad-based exposure to the U.S. pharmaceuticals sector, making it a good option for investing in the industry.
- XPH tracks the performance of the S&P Pharmaceuticals Select Industry Index and provides a cost-effective way to gain exposure to the sector.
- The top holdings of XPH include Axsome Therapeutics, Eli Lilly, Merck & Co., Pfizer, and Jazz Pharmaceuticals, offering diversification and potential for growth within the pharmaceutical sector.
Certain pharmaceutical companies like Eli Lilly have been on fire given the demand for GLP-1 and weight loss medications, but the broader industry should not be disregarded. When it comes to investing in the pharmaceutical industry overall, the SPDR® S&P Pharmaceuticals ETF ( XPH ) is a good option. This exchange-traded fund offers exposure to the U.S. pharmaceuticals sector, allowing investors to gain broad-based exposure to the industry....
Read the full article on Seeking Alpha
For further details see:
XPH: A More Balanced Way To Get Exposure To Pharmaceuticals